Concomitant gut dysbiosis and defective gut barrier serve as the bridges between hypercortisolism and chronic systemic inflammation in Cushing’s disease
Ben Lin(Fudan University), Yifei Yu(Fudan University), Chenxing Ji(Fudan University), Yiming Jiang(Shanghai Medical College of Fudan University), Hongying Ye(Fudan University), Zhengyuan Chen(Fudan University), Chengzhang Shi(Fudan University), Vladimir Melnikov(Fudan University), Hanwen Zhang(Dongguan People’s Hospital), Long Chen(Fudan University), Yiming Li(Central China Normal University), Nidan Qiao(Fudan University), Yichao Zhang(Hangzhou Medical College), Jiajun Chen(Huashan Hospital), Zhen Ye(Fudan University), Qilin Zhang(Fudan University), Yongfei Wang(Fudan University), Meng Wang(Harbin Medical University), Zhan Cao(Tongji University), Zengyi Ma(Fudan University), Zhaoyun Zhang(Fudan University), Zhao Ye(Fudan University), Shuzhen Guo(Shanghai Medical College of Fudan University), Jianxin Wang(China Academy of Engineering Physics), Renyuan Gao(Tongji University)
Cited by 6
Related Papers
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
|Seminars in Cancer Biology|2019|1k
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
|Molecular Therapy|2019|513
RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
|Molecular Cancer|2020|396
LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA‐215
|Journal of Cellular Physiology|2018|301